Skip to main content

Yulong Eco-Materials Limited (YECO)

New York Stock Exchange Healthcare BiotechnologyView data quality →
30.9Poor

ValueMarkers Composite Index

Top 0%#44,516 of 44,707
Overvalued

499% above intrinsic value ($0)

UndervaluedFair ValueOvervalued
Piotroski
4/9
Neutral
Beneish
-2.24
Low Risk
Altman
-151.95
Distress
DCF Value
$0
Overvalued
ROIC
6.1%
Low
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Yulong Eco-Materials Limited (YECO) — VMCI valuation read

YECO screens at VMCI 31/100, a 19-point gap below the Healthcare sector median (50). For a mid-cap Yulong Eco-Materials Limited share, that placement says the multi-pillar composite is richer or lower quality than the typical peer on a like-for-like basis.

YECO has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: YECO trades at 18.0x earnings, 0% above the Healthcare median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Healthcare group. Quality: ROIC of 16.0% sits 6.0pp above the Healthcare median (10.0%), the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of 1.5x leaves covenant headroom, which sets the rate-cycle exposure for Yulong Eco-Materials Limited.

YECO fell 1.6% over the trailing 7 days, with a -5.6% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in YECO’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.